Novavax, an American biotech company, has recently released the promising findings of its experimental COVID vaccine, demonstrating more than 90% efficacy in preventing symptomatic disease. In addition, the vaccine candidate demonstrated 91% efficacy in older patients with certain comorbidities.
Related Articles
The post Novavax Vaccine Demonstrates More Than 90% Efficacy in Preventing COVID appeared first on Latest Health & Medical News – Myhealthyclick.com.